聚-4-羟基丁酸酯补片用于腹壁疝修补的前瞻性初步研究
该前瞻性初步研究评估了31例采用聚-4-羟基丁酸酯(P4HB)可吸收补片经Rives-Stoppa入路行腹壁疝修补的患者,随访24个月。结果显示手术部位并发症发生率为19%,疝复发率为0%,SF-12生理及角色情感维度生活质量较基线显著改善(p<0.05)。
要点
- P4HB可吸收补片用于腹壁疝修补在初步研究中可行,早期未观察到复发。
- 手术部位并发症发生率为19%,以血清肿为主。
- 24个月时SF-12生理及角色情感维度生活质量较基线显著改善。
核心结论
- P4HB可吸收补片行腹壁疝修补获得良好结局,早期未发现疝复发,24个月生活质量较基线改善。
研究设计与样本
- IRB批准的前瞻性初步研究,31例患者经Rives-Stoppa入路行腹壁疝修补并放置P4HB补片于腹膜后间隙。
主要发现
- 手术部位并发症发生率为19%,其中大多数为血清肿。
- 疝复发率为0%,中位随访414天。
- 24个月时SF-12生理成分汇总及角色情感维度较基线显著改善(p<0.05)。
临床怎么用
- 在选取的腹壁疝患者中,P4HB可吸收补片经Rives-Stoppa入路行腹膜后放置是可行的。
局限性
- 本研究为初步研究,样本量有限,需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Biomaterial research has made available a biologically derived fully resorbable poly-4-hydroxybutyrate (P4HB) mesh for use in ventral and incisional hernia repair (VIHR). This study evaluates outcomes of patients undergoing VIHR with P4HB mesh. METHODS: An IRB-approved prospective pilot study was conducted to assess clinical and quality of life (QOL) outcomes for patients undergoing VIHR with P4HB mesh. Perioperative characteristics were defined. Clinical outcomes, employment status, QOL using 12-item short form survey (SF-12), and pain assessments were followed for 24 months postoperatively. RESULTS: 31 patients underwent VIHR with bioresorbable mesh via a Rives-Stoppa approach with retrorectus mesh placement. The median patient age was 52 years, median body mass index was 33 kg/m2, and just over half of the patients were female. Surgical site occurrences occurred in 19% of patients, most of which were seroma. Hernia recurrence rate was 0% (median follow-up = 414 days). Patients had significantly improved QOL at 24 months compared to baseline for SF-12 physical component summary and role emotional (p < 0.05). CONCLUSIONS: Ventral hernia repair with P4HB bioresorbable mesh results in favorable outcomes. Early hernia recurrence was not identified among the patient cohort. Quality of life improvements were noted at 24 months versus baseline for this cohort of patients with bioresorbable mesh. Use of P4HB mesh for ventral hernia repair was found to be feasible in this patient population. (ClinicalTrials.gov Identifier: NCT01863030).
引用
- Plymale MA, Davenport DL, Dugan A, et al. Ventral hernia repair with poly-4-hydroxybutyrate mesh. Surg Endosc. 2017. PMID: 28916979. doi:10.1007/s00464-017-5848-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。